Miller Paula G, Shuler Michael L
Department of Biomedical Engineering, Cornell University, 113 Weill Hall, Ithaca, 14853, New York.
Biotechnol Bioeng. 2016 Oct;113(10):2213-27. doi: 10.1002/bit.25989. Epub 2016 Apr 29.
We describe a human "Body-on-a-chip" device (or microphysiological system) that could be used to emulate drug distribution, metabolism, and action in the body. It is based upon a physiologically based pharmacokinetic-pharmacodynamic (PBPK-PD) model, where multiple chambers representing different organs are connected with fluidic channels to mimic multi-organ interactions within the body. Here we describe a pumpless 14 chamber (13 organs) microfluidic cell culture device that provides a separation between barrier and nonbarrier types of cell cultures. Our barrier chamber layer (skin, GI tract, and lung) allows for direct access and/or exposures to chemical or biological reagents forcing these reagents to pass through a barrier of cells established on a microfabricated membrane before exposing the nonbarrier tissue chambers (fat, kidney, heart, adrenal glands, liver, spleen, pancreas, bone marrow, brain, muscle) or entering the microfluidic circulation within the device. Our nonbarrier tissue chambers were created as three-dimensional configurations by resuspending cells in hydrogel (PGMatrix). We used cell lines to represent five of these organs (barrier lines-A549 [lung] and Caco2 [GI]) (nonbarrier lines-HepG2 C3A [liver], Meg01 [bone marrow], and HK2 [kidney]). The dimensions of our straight duct-like channels to each organ chamber were designed to provide the appropriate flow of a culture medium. The organ volumes and organ flow rates that have been reported for an average human male were used to estimate the desired fluid retention times in each organ chamber. The flow through the channels was induced by gravity on a custom programmed rocker platform which enabled pumpless operation and minimized bubble entrapment. The purpose of this paper is to describe the design and operation of a 14 chamber multi-organ system representing 13 tissues/organs with both barrier and nonbarrier tissue chambers and to study the interactive responses among the various cell lines. We demonstrate that five different cell lines survived with high viability (above 85%) for 7 days. We compared the individual observed flow rates to the compartments to the desired or estimated flow rates. This work demonstrates the feasibility of constructing, operating and maintaining a simple, gravity-driven, multi-organ microphysiological system with the capability of measuring cellular functions such as CYP1A1 and CYP3A4 activities, albumin release, urea, maintenance of tight junctions, and presence of surfactant for a sustained period. Biotechnol. Bioeng. 2016;113: 2213-2227. © 2016 Wiley Periodicals, Inc.
我们描述了一种人体“芯片上的身体”装置(或微生理系统),可用于模拟药物在体内的分布、代谢和作用。它基于生理药代动力学 - 药效学(PBPK - PD)模型,其中代表不同器官的多个腔室通过流体通道相连,以模拟体内多器官间的相互作用。在此,我们描述了一种无泵的14腔室(13个器官)微流控细胞培养装置,该装置可实现屏障型和非屏障型细胞培养的分离。我们的屏障腔室层(皮肤、胃肠道和肺)允许直接接触和/或暴露于化学或生物试剂,迫使这些试剂在接触非屏障组织腔室(脂肪、肾脏、心脏、肾上腺、肝脏、脾脏、胰腺、骨髓、大脑、肌肉)或进入装置内的微流体循环之前,先穿过在微制造膜上建立的细胞屏障。我们的非屏障组织腔室通过将细胞重悬于水凝胶(PGMatrix)中形成三维结构。我们使用细胞系来代表其中五个器官(屏障细胞系 - A549[肺]和Caco2[胃肠道])(非屏障细胞系 - HepG2 C3A[肝脏]、Meg01[骨髓]和HK2[肾脏])。我们为每个器官腔室设计的直管状通道尺寸,旨在提供合适的培养基流速。利用已报道的平均成年男性的器官体积和器官流速,来估计每个器官腔室内所需的液体保留时间。通道内的流动由定制编程的摇床平台上的重力诱导,该平台实现了无泵操作并将气泡截留降至最低。本文的目的是描述一个14腔室多器官系统的设计与操作,该系统代表13个组织/器官,包含屏障和非屏障组织腔室,并研究各种细胞系之间的相互作用反应。我们证明了五种不同的细胞系在7天内以高存活率(高于85%)存活。我们将各个腔室观察到的流速与期望或估计的流速进行了比较。这项工作证明了构建、操作和维持一个简单的、重力驱动的多器官微生理系统的可行性,该系统能够在一段持续时间内测量细胞功能,如CYP1A1和CYP3A4活性、白蛋白释放、尿素、紧密连接的维持以及表面活性剂的存在。《生物技术与生物工程》2016年;113卷:2213 - 2227页。©2016威利期刊公司